Hepatitis B Virus-related Hepatocellular Carcinoma: Epidemiology and Pathogenic Role of Viral Factors
- 1 April 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the Chinese Medical Association
- Vol. 70 (4) , 141-145
Abstract
Chronic hepatitis B virus (HBV) infection is the primary risk factor for the development of hepatocellular carcinoma worldwide. After decades of chronic hepatitis, about 30-40% of patients progress into liver cirrhosis, and of them, around 1-5% subsequently develop hepatocellular carcinoma (HCC) annually. Since the carcinogenic process involves the interplay between the hepatitis virus and the host hepatocytes, both genomes contribute to the final pathogenic outcome, either individually or synergistically. Studying the genetic factors predisposing hepatocarcinogenesis in both host and viral genomes will help illuminate the critical carcinogenic mechanisms, and create molecular targets for future therapy. In this article, we thus review the epidemiology of HBV-related HCC and viral factors involved in hepatocarcinogenesis.Keywords
This publication has 41 references indexed in Scilit:
- Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in TaiwanInternational Journal of Cancer, 2006
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- Epidemiology of Hepatocellular CarcinomaClinics in Liver Disease, 2001
- Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patientsJournal of Gastroenterology, 1998
- Trends in primary liver cancerThe Lancet, 1998
- Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in TaiwanJournal of Gastroenterology and Hepatology, 1997
- Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patientCancer, 1995
- Global programme for control of hepatitis B infectionVaccine, 1995
- From Hepatitis to Hepatoma: Lessons from Type B Viral HepatitisScience, 1993
- The prevalence of anti-hepatitis C virus among chinese patients with hepatocellular carcinomaCancer, 1992